Arterial endothelial expression of α2,8-linked Neu5Gc as a potential target for anti- xeno -antigen inflammation in Cmah -KO mice

Clicks: 21
ID: 331735
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #43 of 72 articles by views in glycobiology

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
N-glycolylneuraminic acid (Neu5Gc), one of the two major sialic acid species in mammals, cannot be biosynthesized in humans because of the inactivation of the responsible enzyme, CMP-Neu5Ac hydroxylase (CMAH). Consequently, Neu5Gc is recognized as an immunologically foreign molecule, resulting in anti-Neu5Gc antibodies production in humans. Meanwhile, dietary Neu5Gc can be metabolically incorporated into glycans and expressed on tissues. Neu5Gc therefore functions as a xeno-autoantigen in humans. The co-existence of Neu5Gc-containing molecules in tissues and circulating anti-Neu5Gc antibodies is thought to drive human-specific chronic inflammation termed xenosialitis and may contribute to vascular disease such as atherosclerosis. Vascular endothelium is a potential major site of Neu5Gc accumulation. Here, we propose the pathological significance of Neu5Gc accumulation likely depends not only on its presence, but also on the glycan structures on which it is displayed. These endothelial Neu5Gc-containing structures remain poorly defined because of the lack of anti-Neu5Gc antibodies to distinguish linkage- and context-specific epitopes. Here, we characterized a vascular Neu5Gc-containing glycan epitope using novel anti-Neu5Gc monoclonal antibodies. Immunohistochemical analyses of mouse tissues showed enriched localization of the epitope for anti-Neu5Gc monoclonal antibody, #23-5, on arterial endothelium. By correlation analysis of glycosyltransferase gene expression and biochemical analyses, the epitope recognized by #23-5 was identified as an α2,8-linked Neu5Gc-containing disialyl structure. In vivo induction of the #23-5 epitope as a xeno-autoantigen was confirmed using Cmah knockout (Cmah-KO) mice after two days of intravenous administration of per-acetylated ManNGc. These findings provide a structural foundation for future studies of Neu5Gc-dependent vascular xenosialitis.
Reference Key
openalex_W7220680173 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Motoki Igakura, Yuko Naito‐Matsui, Yumina Eguchi, Yuki Yamato, Shuhei Takada, Chihiro Sato, Shogo Oka, Roger A. Laine, Hiromu Takematsu
Are you one of these authors? Claim your profile
Journal glycobiology
Year 2026
DOI
10.1093/glycob/cwag086
URL
https://doi.org/10.1093/glycob/cwag086
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.